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Recently, our laboratory demonstrated enhanced sympathetic control of the heart at baseline and in response to adrenergic stimulation in a conscious canine model during the development of hypertension (11, 20, 39) . However, the extent to which peripheral vascular sensitivity to adrenergic stimulation is enhanced in the development of hypertension remains controversial. On the one hand, several studies have suggested that hypertension induces a nonspecific amplification of vascular responses to all pressor agents (2,6,&g, 21,42) . In contrast to this view, other laboratories have argued that the enhanced vascular reactivity in hypertension is selective for only certain agonists and that selective enhancement to either a-adrenergic agonists (14, Z), angiotensin II (4) or vasopressin (15, 18) , may be an integral part in the pathogenesis of hypertension.
If selective enhancement occurred, it would probably be mediated by alterations in receptor binding in contrast to alterations in vascular structure. It is also possible that increased circulating levels of angiotensin II, common to several types of hypertension, enhance responses to vasoconstrictors.
In support of this, there are several studies in normotensive animals demonstrating increased pressor and vasoconstrictor responses in the presence of low levels of angiotensin II infusion, most notably to norepinephrine (17, 35, 36, 41) .
Accordingly, the primary goal of the present investigation was to test the hypothesis that the initial development of hypertension is characterized by enhanced vasoconstrictor responsiveness to a,-adrenergic stimulation, an effect that is mediated by the changes in the number or affinity of the al-adrenergic receptors. To achieve these goals, the effects of the infusions of adrenergic (norepinephrine, phenylephrine) and nonadrenergic vasoconstrictors (angiotensin II, vasopressin) were examined on measurements of arterial pressure and total peripheral resistance to assess sensitivity of peripheral resistance vessels. Because it was feasible to examine al-adrenergic receptor density in a large artery such as the aorta and because it was desirable to correlate in vitro binding data with in vivo physiological responsiveness, it was necessary to assess the reactivity of the same vessel, i.e., aorta, to the vasoconstrictors studied. To accomplish this goal, aortic pressure-diameter relationships in the same intact conscious dogs during normotension and after the initial development of perinephritic hypertension were examined. These data were correlated with measurement of the density and affinity of cyl -adrenergic receptors in aortic sarcolemmal preparations from the hypertensive dogs and compared with results from control animals. Finally, to determine if increased circulating angiotensin II enhances the responses to adrenergic or nonadrenergic vasoconstrictors, the effects of norepinephrine, phenylephrine, and vasopressin were examined in normotensive conscious dogs in the presence and absence of angiotensin II. To determine the extent to which reflex mechanisms were responsible for the observed enhanced sensitivity to vasoconstrictor agonists, all physiological experiments were conducted in the presence and absence of ganglionic blockade.
H1260
INCREASED al-ADRENERGIC VASCULAR SENSITIVITY IN HYPERTENSION output), an electromagnetic flow probe (Zepeda Instruments, Seattle, WA) or transonic probe (Transonic Systems, Ithaca, NY) was implanted around the root of the ascending aorta in eight dogs. Two 5mHz piezoelectric crystal transducers, each attached to a Dacron patch, were sutured on opposing sites in the adventitia of the thoracic descending aorta l-2 cm distal to the implanted aortic catheters. The output of the sonomicrometer was monitored on an oscilloscope to identify the largest diameter and the greatest amplitude, which indicate optimal alignment between the two crystals. In three dogs hydraulic occluders were also implanted distal to the crystals, with care not to affect the measurement of aortic diameter. All lead wires and catheters were tunneled subcutaneously to the interscapular region of the back. The thoracotomy was closed, and animals were allowed to recover for 3-4 wk. Perinephritic hypertension was induced after completion of control experiments according to the method introduced by Page (33) and used previously in our laboratory (11, 20, 39) . The left kidney was wrapped in a silk pouch through a left flank incision. Care was taken not to cause stenosis of the renal artery. A contralateral nephrectomy was carried out 1 wk later through a right flank incision. All surgeries were performed using sterile technique and general anesthe sia. Measurements.
Hemodynamic measurements were recorded on a multichannel tape recorder (Honeywell, Denver, CO) and played back on a direct writing oscillograph (Gould-Brush, Cleveland, OH). Fluid-filled catheters in the aorta and left and right atrium were connected to strain-gauge manometers (Statham Instruments, Oxnard, CA) for the measurement of arterial (aortic) and atria1 pressures. A square-wave electromag netic flowmeter (Benton Instruments, Cupertino, CA) or a Transonic flowmeter was used to measure cardiac output. The flow probes were calibrated in vitro using timed blood collections in a gravity flow system. Zero aortic flow was assumed to occur during mid-and late diastole. External aortic diameter was measured using the ultrasonic dimension technique (31, 32) . This technique measures the transit time of acoustic impulses traveling at the sonic velocity of -1.5 x lo6 mm/s between the pairs of implanted piezoelectric crystals. Calibration of the dimension gauge was performed by substituting signals of known duration from a calibrated pulse generator. A voltage proportional to transit time was recorded and calibrated in terms of crystal separation. At a constant room temperature, the drift of this instrument is minimal, ~0.01 mm in 6 h. Any drift that may have occurred was eliminated by repeated calibration reference throughout each experiment.
Mean aortic pressure, mean right or left atria1 pressure, and mean external aortic diameter were assessed using resistancecapacitance (RC) filters with 2-s time constants, whereas RC filters with 8-s time constants were used to obtain mean ascending aortic blood flow, i.e., cardiac output minus coronary blood flow. Vascular responsiveness in resistance vessels was assessed by evaluation of changes in mean arterial pressure and total peripheral resistance to infusions of vasoconstrictors. Total peripheral resistance was calculated as the quotient of mean arterial pressure and cardiac output. Aortic pressureexternal aortic diameter relationships were studied to assess the aortic vascular responsiveness by plotting the changes in mean aortic pressure and mean external aortic diameter in response to the interventions.
Blood samples were taken for the measurements of plasma catecholamine concentration and plasma renin activity. Plasma catecholamine levels were determined by the method of Peuler and Johnson (34). Plasma renin activity was determined by a radioimmunoassay for angiotensin I based on the method of Haber et al. (13) .
Protocols. Experiments were initiated 3-4 wk after instrumentation, when the animals were healthy and vigorous. Dogs were studied in the conscious state while resting quietly on the table. The responses to randomized 5-to 6-min intravenous infusions of graded doses of norepinephrine (NE; 0.05, 0.1, 0.2, and 0.5 pg=kg-l emi&), phenylephrine (PE; 0.5, 1, and 2 pg-kg-l* min-l), angiotensin II (ANG II; 0.005, 0.02, and 0.05 pg. kg-l l min-l), and vasopressin (VP; 0.5, 2, and 10 mIU 9 kg-l . min l) were examined while continuously recording measurements of cardiac output, external aortic diameter, aortic and atria1 pressures, and heart rate. On a separate day the effects of the infusions of those agonists were evaluated also in the presence of ganglionic blockade with hexamethonium (30 mg/kg) and atropine (0.1 mg/kg) to abolish autonomic reflex influences on peripheral vasculature. In the presence of ganglionic blockade, graded doses of NE (0.01, 0.02, and 0.06 pg*kg-lbrnin-l), PE (0.1,0.2, and 0.6 ~g~kg-l~min-l), ANG II (0.002, 0.005, and 0.01 pg*kg-l amin+), and VP (0.1, 0.2, and 1.0 mIU l kg-l l min-l) were administered. The efficacy of ganglionic blockade was tested by the absence of heart rate responses to bolus injections of PE (3 pg/kg iv) and nitroglycerin (5 pg/kg iv). In three dogs, aortic pressure-diameter relationships were also evaluated in the presence and absence of hypertension on the response to a change in aortic pressure produced mechanically by inflating the hydraulic occluder implanted on the descending aorta. Data points for analysis of all parameters were taken at the stable state before and during the infusions of each dose of the agonists. These interventions were repeated during the development of hypertension, i.e., when mean arterial pressure had increased to 120 mmHg. One dog was studied at only l-2 wk after renal wrapping, without nephrectomy, because mean arterial pressure was already at 120 mmHg. Four dogs were studied at 2 wk, five dogs at 3 wk, and three dogs at 4 wk after renal wrapping. In five dogs the effects of interventions were studied at more than one time point during the period of 2-5 wk after renal wrapping. In another set of five conscious dogs, the responses to randomized 5 min intravenous infusion of two graded doses of NE (0.1 and 0.2 pg. kg-l l min-l), PE (1.0 and 2.0 pg*kg-lamin+), and VP (1 and 2 mIU l kg-l l min-l) were examined. On the same day, these experiments were repeated after continuous infusion of low doses of ANG II (0.006-0.008 pg. kg-l amin-l), which elevated mean arterial pressure by -15 mmHg from the baseline level. On a separate day, after ganglionic blockade with hexamethonium and atropine, graded doses of NE (0.02 and 0.06 pg*kg-l l min-l), PE (0.2 and 0.6 pge kg-l amin-l), and VP (0.2 and 1 mIU . kg-l l min-l) were administered in the absence and then in the presence of infusion of ANG II (0.002-0.004 ,ug*kg+ min-l), which also elevated mean arterial pressure by -15 mmHg from the baseline level.
Biochemical studies. After the physiological studies were completed, dogs were anesthetized with pentobarbital sodium (25 mg/kg), and the entire aorta was excised for cyl adrenergic receptor assay and Na+-K+-adenosinetriphosphatase (ATPase) measurements. The aorta was placed in ice-cold buffer A [(in mM) 250 sucrose, IO iV-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, IO phenylmethylsulfonyl fluoride (PMSF), and 10 benzamidine, pH 7.51 and dissected free of surrounding fat. Aortic vascular smooth muscle membrane preparations were obtained as follows: the minced tissue was disrupted with two 10-s bursts with the use of a Brinkman polytron S20 (setting 10) followed by filtration through a 12-gauge silk screen. Undisrupted aggregates were then pelleted by centrifugation at 1,000 g for 15 min (Sorvall RC-5B). The supernatant was centrifuged at 210,000 g (Sorvall ultracentrifuge) to obtain the microsomal pellet. The microsomal pellet was resuspended in buffer B [(in mM) 100 tris(hydroxymethyl)aminomethane, 5 ethylene glycolbis(P-aminoethyl ether)-N,N,N',N'-tetraacetic acid, 10 PMSF, 10 benzamidine, pH 7.51 by homogenization and subsequently repelleted and rehomogenized into the same buffer to a protein concentration of 4-6 mg/ml before storing at -70°C. Five additional aortas were studied by substituting centrifugation at 50,000 g for centrifugation at 210,000 g. There was no significant difference in the density of al adrenergic receptors in these two fractions. The yield of membrane protein was 1.5 mg/g wet wt. The average yield of protein for the undisrupted aggregate fraction was 500 pg protein from an entire canine aorta. Ligand binding studies failed to detect cu,-adrenergic receptors in this fraction.
Binding of [3H Jprazosin to the membrane preparation was performed in triplicate in a total volume of 500 ~1 by incubating 400-~1 membranes (0.5 mg/ml) with 50 ~1 of the radioligand C3H]prazosin (0.01-3 nM) and 50 ~1 of either buffer or various concentrations of the unlabeled competing drug phentolamine (0.1 nM) at 25°C for 45 min. Unbound radioligand was separated by vacuum filtration on Whatman G/C filters, which were washed four times with 4-ml aliquots of buffer B. The amount of ligand bound was determined by liquid scintillation techniques. In these studies, nonspecific binding was determined in the presence of 0.1 mM phentolamine for the al-antagonist. The dissociation constant (Kp) and receptor density were calculated from Scatchard analysis and from the nontransformed binding data with the mass action law-based curve-fitting LIGAND program of Munson and Rodbard (28) . Na+-K+-ATPase activity was determined by the method of Jones and Besch (19) . The results in hypertensive dogs were compared with those from control dogs, i.e., seven normal dogs and three sham-operated dogs D&z analysis. All data were stored on an IBM PC/AT corn puter. All values are reported as means t SE. The data collected from the same dogs before and after induction of hypertension, or before and after infusion of ANG II, were tested statistically with Student's t test for paired data, whereas the comparison between hypertensive and control dogs was made by Student's t Values are means t SE; n, no. of animals. * P < 0.01, hypertension different from normotension.
test for grouped data. Statistical differences of Aaortic pressureAaortic diameter relationships were examined by comparison of Aaortic diameter-Aaortic pressure relationships in response to the intervention. When multiple comparisons were analyzed, Student's t test with Bonferroni's correction was utilized such that the P value per number of comparisons was co.05 (25).
RESULTS
Baseline values (Table I ). In intact conscious animals, perinephritic hypertension increased (P < 0.01) mean arterial pressure from 91 t 3 to 124 t 4 mmHg and total peripheral resistance from 43.3 t 4.1 to 61.7 -t 4.8 mmHg l 1-l l min-I. In the presence of ganglionic blockade, perinephritic hypertension increased (P < 0.01) mean arterial pressure from 83 $-3 to 127 t 4 mmHg and total peripheral resistance from 38.0 t 1.5 to 56.7 t 3.7 mmHg l 1-l. min-I. No significant changes in baseline values of cardiac output were observed. There was no significant difference in heart rate before and after hypertension. Responses of arterial pressure and total peripheral re-significantly less (P < 0.01) than observed for mean ardance to NE, PE, ANG II, and VP in normotension and terial pressure (55 t 5 mmHg) and total peripheral resishypertension. The effects of one dose of NE, PE, ANG II, tance (29.1 t 4.1 mmHgl-l amin-') in response to the and VP with and without ganglionic blockade on mean same dose of NE in hypertension.
In the presence of arterial pressure and total peripheral resistance are ganglionic blockade, NE (0.06 pg l kg-l. min-l) increased shown in Table 2 , whereas Figs. l-4 present dose-re-mean arterial pressure more (P < 0.01) in hypertension sponse relationships. NE increased arterial pressure and (66 t 4 mmHg) than normotension (42 t 4 mmHg) and total peripheral resistance more in hypertension than increased total peripheral resistance more in hypertenin normotension (Fig. 1) . For example, NE (0.2 pg. sion (29.3 t 3.6 mmHg l 1-l l min-l) than normotension kg -l emin-l) increased mean arterial pressure by 30 t 3 (15.8 t 2.8 mmHg l-l. min-l). mmHg and total peripheral resistance by 11.0 t 1. 6 PE increased mean arterial pressure and total periphmmHg l 1-l. min-l in normotension, increases that were era1 resistance more in hypertension than in normoten- nists were not observed in hypertension (Figs. 3, 4) .
Aortic vascular sensitivity to NE, PE, ANG II, and VP.
in hypertension. In the presence of ganglionic blockade, PE (0.6 pg. kg-l 9 min-l) increased mean arterial pressure The Aaortic pressure-Aaortic diameter relationships during graded NE infusions in normotension and hypertension are shown in Fig. 5A . There were significant differences in the responses of Aaortic pressure-Aaortic diameter relationships to NE between normotension and hypertension, demonstrating a significant shift of the relationship in hypertension from that in normotension. Similar significant differences in Aaortic pressure-Aaortic diameter relationships during graded PE infusions were observed between normotension and hypertension (Fig. 5B) . The Aaortic pressure-Aaortic diameter relationships during graded infusions of ANG II and VP are presented in Fig. 6 . There were no significant differences of Aaortic diameter-Aaortic pressure relationships in the responses to either ANG II or VP infusions between normotensive and hypertensive states.
In three dogs, Aaortic pressure-Aaortic diameter relationships in response to changes in aortic pressure induced by aortic constriction with an implanted hydraulic occluder were examined in normotension and hypertension (Fig. 7) . These relationships induced by mechanical constriction of the aorta were not different in normotension and hypertension.
In the presence of ganglionic blockade after the development of perinephritic hypertension, aortic pressure-diameter relationships were still shifted in comparison with mechanical increases in pressure (P < 0.05), whereas Aaortic pressure-diameter relationships in response to ANG II and VP were not differ- ent from those observed with mechanical increases in pressure (Fig. 8) .
In five dogs the effects of interventions were studied at more than one time point during the period of 2-5 wk after renal wrapping. In these dogs the shift in aortic pressure-diameter relationship was observed at each time point studied. However, in one dog, hypertension was present early (2 wk after renal wrapping) and was no longer apparent at 3 wk after renal wrapping. In that dog, increased responses to NE and PE were observed early after hypertension and were no longer apparent at 3 wk when hypertension was no longer present.
Response of total peripheral resistance to NE, PE, and VP in the presence and absence of ANG II infusion. In a subset of five normotensive conscious dogs, graded doses of NE, PE, and VP were examined first in the absence and then in the presence of ANG II infusion (0.006-0.008 ww . min-l). ANG II infusion induced mild hypertension, increasing mean arterial pressure from 89 t 1 to 106 t 1 mmHg (P < 0.01) and total peripheral resistance from 45 t 2 to 57 t 3 mmHg+l emin-l (P < 0.01). In the absence of ANG II infusion, the NE (0.2 hge kg-l -min-l), PE (2.0 pg=kg-l . min-l), and VP (2.0 mIU kg-' amin) increased total peripheral resistance by 16 t 3, 50 t 9, and 48 t 9 mmHg l 1-l l min-', respectively. In the presence of ANG II infusion, the same doses of NE, PE, and VP increased total peripheral resistance by greater amounts, P < 0.05, i.e., by 34 t 9, 68 t 11, and 70 t 9 mmHgl-l*min-l, respectively (Fig. 9) . Enhanced vasoconstrictor responses in the presence of ANG II were noted at all doses studied.
After ganglionic blockade, ANG II infusion also induced mild hypertension, increasing mean arterial pressure from 81 t 2 to 95 t 2 mmHg (P c 0.01) and total peripheral resistance from 38 t 2 to 47 t 2 mmHg l l-l l min-l (P < O.Ol), respectively. Vasoconstrictor responses to NE and PE were no longer enhanced by ANG II infusion, i.e., NE (0.06 pge kg-l. min-l) and PE (0.6 pg. kg-l l min-l) increased total peripheral resistance by 23 t 2 and 26 t 6 mmHg+l l mine1 in the absence of ANG II infusion and by 23 t 2 and 27 t 7 mmHg . l-' l mine1 in the presence of ANG II infusion, respectively. The increase in total peripheral resistance response to VP (1.0 mIU . kg-l. min-l) was even less (P < 0.05) in the presence of ANG II infusion (39 t 3 mmHg l 1-l emin-') than that observed in the absence of ANG II (50 t 5 mmHg 9 1-l l min-l; Fig. 9 ). In contrast to what was observed in hypertension, enhanced responsiveness to NE, PE, and VP was not observed during ANG II infusion at any dose studied.
Biochemical data. The results of biochemical studies are summarized in Table 3 . In sarcolemmal preparations of aortic smooth muscle. the cul-adrenergic receptor den- Na+-K+-ATPase activity in aortic smooth muscle, a membrane marker, was also similar between the hypertensive and control dogs (0.89 t 0.34 vs. 0.88 t 0.17 pmol Pi*h-l*mg-l).
Circulating catecholamines and plasma renin activity. Plasma NE levels were not different between hypertension (212 t 23 pg/ml) and normotension (209 t 42 pg/ ml). Similar levels of plasma epinephrine were observed before and after hypertension (155 t 26 vs. 147 t 22 pg/ml). Plasma renin activity in hypertension (1.2 t 0.5 ng aneiotensin 1. ml-l ah-l) was not different from that 
DISCUSSION
One of the fundamental issues to be resolved for understanding the pathogenesis of hypertension is whether or not vascular sensitivity is altered during the development of the disease state and, if so, whether the alterations in vascular sensitivity occur in response to all vasoconstrictors. A secondary related question is whether the large arteries and resistance vessels are involved. An integral feature of this study was the comparison of physiological responsiveness to cyl -adrenergic stimulation and arl-adrenergic receptor density in the same tissues, i.e., the canine aorta. The major finding in the current investigation was that vascular responsiveness to a,-adrenergic stimulation with NE and PE is enhanced during the development of hypertension, whereas responsiveness to nonadrenergic agents, e.g., ANG II or VP, was not augmented. The enhanced reactivity was observed in both large arteries, i.e., aorta, as reflected by changes in pressure-diameter relationships, and also in resistance vessels, as reflected by changes in arterial pressure and total peripheral resistance in response to adrenergic stimulation during the development of perinephritic hypertension. It appears that the enhanced al-adrenergic receptor responsiveness during the development of hypertension may be mediated by increased al-adrenergic receptor density, which was observed in sarcolemmal preparations from aortas of hypertensive dogs.
A nonspecific enhancement of vascular reactivity has been suggested in some studies of hypertension, suggesting structural amplifier effects of the vasculature (2, 6, 8, 9,21,42), whereas other studies, even when using models similar to those in which generalized enhanced reactivity was observed, found only selective enhancement in reactivity (6, 14, 15, 18, 22) . For example, this field is further confounded by finding selective enhancement to ANG II (4), VP (15, la), and adrenergic agonists (14, 22) and even studies observing the opposite, i.e., reduced sensitivity to NE in hypertension (7). The reasons for this marked diversity of findings are not clear. It is possible that species differences, models of hypertension, duration of hypertension, study of large vs. resistance vessels, cardiovascular reflex buffering of agonists, and the presence or absence of general anesthesia and recent surgery may all play a role in this controversy. For example, with more prolonged hypertension and consequently greater mass of vascular smooth muscle, a nonspecific enhancement of vascular reactivity might be observed more readily. Second, differences due to the model of hypertension must also be considered, particularly due to potential differences in levels of circulating hormones.
The present study examined both reactivity of resistance vessels and large arteries. Reactivity of resistance vessels was assessed by pressor and vasoconstrictor response to graded doses of NE, PE, VP, and ANG II. In contrast to responses of arterial pressure and total peripheral resistance to VP and ANG II, which appeared unaltered by the development of hypertension, pressor AR SENSITIVITY IN HYPERTENSION and vasoconstrictor responses to NE and PE were augmented in the same animals during developing hypertension. Vascular sensitivity in large arteries and the aorta has been studied in vitro, whereas there is little known about vascular sensitivity of large arteries in vivo, especially in intact conscious animals with hypertension. In the present study, the evaluations of Aaortic pressureAaortic diameter relationships by direct measurements of mean external aortic diameter and mean aortic pressure made it possible to assess the aortic vascular responsiveness to the agonists and demonstrated that the relationships were shifted substantially during al-adrenergic stimulation in hypertension from those in normotension, but these relationships were unaltered in response to ANG II, VP, or mechanical increases in aortic pressure. The smaller aortic diameter at any given aortic distending pressure, as compared with responses to mechanical changes in aortic distending pessure, represented the active constriction of aortic smooth muscle. It is interesting to note that a clinical study measuring arterial diameter in the forearm indirectly demonstrated hyperresponsiveness to NE in hypertensive subjects (23) .
One might argue that reflex effects could mask differential reactivity.
Accordingly, experiments were also conducted in the presence of ganglionic blockade with hexamethonium and atropine, where pressor and vasoconstrictor responses and aortic pressure-diameter relationships to NE and PE were still enhanced but responses to ANG II and VP still were not altered in hypertension. These experiments indicate that the enhanced vasoconstrictor activity to al-adrenergic agonists is a direct action and is not reflexly mediated. In this regard, the finding in the present investigation of enhanced vascular responsiveness to NE and PE in hypertension is in agreement with several prior studies (2,3,9, 14,21,22,29,4O, 42). The major point of disagreement with prior concepts is the finding that the increased crl-adrenergic vasoconstrictor reactivity is not shared with other vasoconstrictors, e.g., ANG II and VP, and, therefore, is not consistent with the "amplifier" hypothesis (2, 6, 8, 9, 21, 42). There are several potential mechanisms responsible for the selective enhancement of vasoconstrictor responses to NE and PE. Elevated plasma levels of VP have been reported in some models of experimental hypertension (5, 26, 27), but VP does not enhance the vasoconstrictor action of NE (30) . On the other hand, it has been shown that elevated ANG II levels may potentiate NE vasoconstrictor reactivity (17, 35, 36, 41) . Thus elevation of plasma ANG II could be a component in the mechanism of the enhancement of vascular sensitivity to cul-adrenergic stimulation observed in the hypertensive state. However, it is important to note that, in the current investigation, there was no significant difference of plasma renin activity between normotension and hypertension. It is further unlikely that an interaction with other hormones is the sole mechanism responsible for enhanced al-adrenergic receptor sensitivity in hypertension in the present study, since direct assessment of al-adrenergic receptor binding demonstrated increased receptor density in aortic membrane preparations.
Despite these arguments, it was felt important to test the hypothesis that enhanced vasoconstrictor responses to PE and NE were due solely to increases in ANG II levels that could have occurred but were not detected. Accordingly, we examined this possibility in a subset of normotensive dogs (Fig. 9) . Indeed, low levels of ANG II infusion sufficient to increase arterial pressure by -15 mmHg did enhance vasoconstrictor responses to NE and PE. However, in contrast to what was observed in developing hypertension, in the presence of low doses of ANG II, enhanced responsiveness to VP was also observed, i.e., the augmented responses were not selective to a-adrenergic agonists. In further contrast to the pattern observed in developing hypertension, in the presence of low doses of ANG II after ganglionic blockade enhanced responsiveness to NE and PE was no longer observed, and the response to VP actually decreased under these conditions, which could have been due to an interaction between ANG II and VP. These distinct differences in data rule out the possibility that our results of selectively enhanced responsiveness of PE and NE during developing hypertension are due solely to increased circulating ANG II levels, since if this were the mechanism, it would still have been apparent after ganglionic blockade. Rather, the results from the experiments with ANG II infusion can be explained most likely on the basis that ANG II could have affected baroreflex circulatory control (10, 12, 38) , a mechanism that would not be operative in the presence of ganglionic blockade. Nevertheless, increased ANG II levels during developing hypertension could contribute to enhancd vascular sensitivity to vasoconstrictors through altered baroreflex mechanisms. This enhanced sensitivity is nonselective, since the mechanism involves altered baroreflex control as opposed to effects on a vascular receptor.
There is little agreement from prior studies on the direction of changes in al-adrenergic receptor density in vascular tissue in hypertension (24) . Not only increases (16, 37) but also no change (1, 3 ,40) or even decreases (37) in the density of vascular a,-adrenergic receptors in hypertension have been reported. These controversial data on al-adrenergic receptors could be explained because of differences in animal species, types of hypertension, and diversity of organ tissue. In the present investigation, we conclude that the increased density of binding sites of a,-adrenergic receptors is one potential mechanism for the enhancement of vascular reactivity This conclusion is based solidly on combined physiological and biochemical data from the aorta. Whereas supportive physiological data were collected for resistance vessels, i.e., assessment of responses of total peripheral resistance to ac-adrenergic vasoconstrictors, measurements of al-adrenergic receptor density were only made in the aorta. Similar conclusions could not have been derived from prior studies, since those studies demonstrating increased vascular sensitivity to a1 -adrenergic stimulation in hypertension either did not assess vascular ai-adrenergic receptor density in vitro (2,9,14,21,22,29, 42) or did make the measurements but failed to observe increased binding sites (3, 40) . Conversely, other studies either failed to observe increased a,-adrenergic receptor density (1) or demonstrated increased al-adrenergic receptor density in vitro (16) but did not observe increased vascular reactivity in vivo. One difference in technical procedure between this study and others is that we used large animals, i.e., dogs, whereas small animals, i.e., rats, were studied in those studies. It is likely that the arterial tissue from large animals provides more tissue protein, as compared with that from small animals, which will result in a more reliable Scatchard analysis. Indeed, the only other study in which q-adrenergic receptors were measured in large animals, i.e., baboons with chronic hypertension, demonstrated increased al-adrenergic receptors in arterial tissue (16) .
In summary, during the development of perinephritic hypertension in the conscious dog, increased vascular responsiveness to the ar-adrenergic receptor agonists NE and PE was observed in the large artery (altered aortic pressure-diameter relationships) and in the resistance vessels (increased arterial pressure and total peripheral resistance responses). These changes were not accompanied by enhanced responsiveness to other vasoconstrictors, e.g., ANG II and VP, thereby not supporting the amplifier hypothesis but were accompanied by increases in aortic vascular al-adrenergic receptor density, as assessed by ligand binding. This pattern of selectively enhanced responsiveness to al-adrenergic receptor agonists differed from the enhanced vascular responsiveness observed with simple elevation of circulating ANG II and was different from that predicted by the "amplifier hypothesis."
